Pharmacy Drugs
Recent Posts
- Lytix Biopharma AS Announces Regulatory Approval By Norwegian And Swedish Authorities To Commence Phase I Clinical Trial Of OncoporeTM In Cancer
- NPA Responds To Quality Accounts Consultation, UK
- Novelos Therapeutics’ (NVLT.OB) CEO Is Eyeing “Revolutionary” Phase III Study Results
- Investigational Dual Orexin Receptor Antagonist Almorexant Meets Primary Endpoint In Two-week Phase III Study Of Primary Insomnia
- PHT Corporation’s Market Leading LogPad And StudyWorksTM EPRO Solutions Used In Sanofi Pasteur’s Phase II Study Of New Clostridium Difficile Vaccine
Random Posts
- Altus Pharmaceuticals Reports Dosing First Patient In A Phase 2 Trial Of ALTU-238 For Pediatric Growth Hormone Deficiency
- Bayer Presents Positive Phase II Data With Florbetaben Potential To Visualize Beta-Amyloid Plaques In Patients With Alzheimer's Disease
- Depomed Completes Enrollment Of Phase 3 Clinical Program Of DM-1796 In Post-Herpetic Neuralgia
- Medical Care Sought In Mexico By Nearly 1 Million Californians Annually
- Watson Pharmaceuticals Receives A Complete Response Letter For Its 24-Week Formulation Of TRELSTAR(R) (triptorelin Pamoate) NDA From US FDA
- Few Pharmacies Can Translate Prescription Labels Into Spanish
- Cimzia(R) (certolizumab Pegol) Now Available For Self-Administration In Adult Patients With Moderate To Severe Crohn's Disease
- Spike in Branded Drug Prices Drives Hike in Overall Drug Spending
- PEAK Surgical Announces First Use Of PEAK PlasmaBlade(TM) In Europe
- Néovacs To Expand Clinical Testing Of Its TNF-alpha Kinoid Lead Product Candidate Following Positive Preliminary Findings From A Phase I/II Study
Pharmacy Bodies Call For Reinstatement Of Community Pharmacists To The Shortage Occupations List, UK
Posted by: admin in Pharmacy Drugs on July 25th, 2009
The CCA, AIMp, BPSA, and NPA are appealing for an immediate reinstatement of community pharmacists to the Shortage Occupations List after the removal of community pharmacists from the list by the Migration Advisory Committee (MAC) last month.
The pharmacy bodies have submitted evidence jointly to MAC of the shortage of community pharmacists and the need for non-EU pharmacists to be permitted to work in UK community pharmacy.
The evidence submitted includes workforce statistics that demonstrate the difficulty in assessing the number of pharmacists required from simply looking at the workforce census data. In addition the picture is not uniform across the country and several areas of the UK have particularly hard to fill vacancies.
There is an increased demand for community pharmacists due to the rise in pharmacy numbers throughout the United Kingdom (2008 to 2009), increasing opening hours and demand for pharmacists to deliver additional services.
The MAC decision has practical consequences for pharmacy businesses and human consequences. Amongst others, it affects non-EU overseas pharmacists in the UK who have just completed their diploma and who have had offers of pre-registration training jeopardised by the ruling. BPSA has submitted evidence of the hardship being caused to these students. The decision, if not reversed, will have a consequential impact of registrations in 2010.
The pharmacy bodies are asking for an urgent meeting with the MAC secretariat and officials from the UK Border Agency to argue for an immediate reinstatement of community pharmacies onto the Shortage Occupations List.
Source
National Pharmacy Association